Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Biodesix (BDSX) Gross Margin (2019 - 2026)

Biodesix filings provide 8 years of Gross Margin readings, the most recent being 83.55% for Q1 2026.

  • On a quarterly basis, Gross Margin rose 417.0% to 83.55% in Q1 2026 year-over-year; TTM through Mar 2026 was 85.12%, a 400.0% decrease, with the full-year FY2025 number at 91.46%, up 207.0% from a year prior.
  • Gross Margin hit 83.55% in Q1 2026 for Biodesix, down from 93.18% in the prior quarter.
  • In the past five years, Gross Margin ranged from a high of 117.9% in Q4 2024 to a low of 50.6% in Q1 2022.
  • Median Gross Margin over the past 5 years was 77.0% (2023), compared with a mean of 77.28%.
  • Biggest five-year swings in Gross Margin: surged 4090bps in 2024 and later crashed -2472bps in 2025.
  • Biodesix's Gross Margin stood at 65.59% in 2022, then increased by 17bps to 77.0% in 2023, then soared by 53bps to 117.9% in 2024, then fell by -21bps to 93.18% in 2025, then dropped by -10bps to 83.55% in 2026.
  • The last three reported values for Gross Margin were 83.55% (Q1 2026), 93.18% (Q4 2025), and 81.14% (Q3 2025) per Business Quant data.